Zylera Pharmaceuticals entered the industry of in 2006 and has grown to employ 1 to 4 people, generating an annual revenue of $10.000.000 to $19.9999.999. The NAICS classifies this business under the code 4242101, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Phillip Tabbiner, Chief Executive Officer by calling (919) 313-3560 during business hours. You can also write to the business’ Single Location at 510 Meadowmont Village Circle 272, Chapel Hill, North Carolina NC 27517. You can also visit the company’s website at zylera.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Zylera Pharmaceuticals |
Representative: | Phillip Tabbiner, Chief Executive Officer |
Place of Business: | 510 Meadowmont Village Circle 272, Chapel Hill, NC 27517 |
Contact Number: | (919) 313-3560 |
Website: | zylera.com |
Type of Service: | |
SIC Number: | 5912 |
NAICS Number: | 4242101 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2006 |
Income/Year: | $10.000.000 to $19.9999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Zylera Pharmaceuticals is a company operating from Orange, North Carolina providing professional and relevant B2C variables. It was founded in 2006 and registered with the SIC code 5912 as , and with the NAICS code 4242101 as .
With a current employee count of 1 to 4, Zylera Pharmaceuticals has gone to report making $10.000.000 to $19.9999.999 per annum on its journey towards growth. This company invites you to contact its representative Phillip Tabbiner, Chief Executive Officer at (919) 313-3560 for related queries, or to locate its Single Location using the coordinates 35.90543,-79.01053.
The Single Location can also be found at the street address 510 Meadowmont Village Circle 272 in Chapel Hill, North Carolina 27517 and can be engaged online through the company website at zylera.com, the company Twitter , and Facebook page .